Literature DB >> 19139198

Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2.

Lorna M Friis1, Monika Keelan, Diane E Taylor.   

Abstract

Gastrointestinal disease caused by Campylobacter jejuni is characterized by localized inflammation and the destruction of the epithelial cell barrier that forms host innate protection against pathogens. This can lead to an imbalance in fluid transport across the gastrointestinal tract, resulting in severe diarrhea. The mechanisms of host cell receptor recognition of C. jejuni and downstream immune signaling pathways leading to this inflammatory disease, however, remain unclear. The aim of this study was to analyze the mechanisms involved in C. jejuni induction of the acute-phase inflammatory response regulator interleukin-6 (IL-6). Polarized intestinal epithelial Caco-2 monolayers responded to infections with Salmonella enterica serovar Typhimurium and eight isolates of C. jejuni by an increase in levels of expression and secretion of IL-6. No such IL-6 response, however, was produced upon infection with the human commensal organism Lactobacillus rhamnosus GG. The IL-6 signaling pathway was further characterized using short interfering RNA complexes to block gene expression. The inhibition of myeloid differentiation primary response protein 88 (MyD88) expression in this manner did not affect C. jejuni-induced IL-6 secretion, suggesting a MyD88-independent route to IL-6 signal transduction in C. jejuni-infected human epithelial cells. However, a significant reduction in levels of IL-6 was evident in the absence of Toll-like receptor 2 (TLR-2) expression, implying a requirement for TLR-2 in C. jejuni recognition. Caco-2 cells were also treated with heat-inactivated and purified membrane components of C. jejuni to isolate the factor responsible for triggering IL-6 signaling. The results demonstrate that C. jejuni surface polysaccharides induce IL-6 secretion from intestinal epithelial cells via TLR-2 in a MyD88-independent manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139198      PMCID: PMC2663148          DOI: 10.1128/IAI.00707-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

Review 1.  In vitro cell culture methods for investigating Campylobacter invasion mechanisms.

Authors:  L M Friis; C Pin; B M Pearson; J M Wells
Journal:  J Microbiol Methods       Date:  2005-05       Impact factor: 2.363

Review 2.  Directing transition from innate to acquired immunity: defining a role for IL-6.

Authors:  Simon A Jones
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

3.  Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.

Authors:  Elizabeth Furrie; Sandra Macfarlane; George Thomson; George T Macfarlane
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

4.  Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin.

Authors:  Thomas E Hickey; Gary Majam; Patricia Guerry
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Campylobacter jejuni inhibits the absorptive transport functions of Caco-2 cells and disrupts cellular tight junctions.

Authors:  Amanda MacCallum; Simon P Hardy; Paul H Everest
Journal:  Microbiology (Reading)       Date:  2005-07       Impact factor: 2.777

6.  Detection and initial characterization of novel capsular polysaccharide among diverse Campylobacter jejuni strains using alcian blue dye.

Authors:  A V Karlyshev; B W Wren
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Involvement of a plasmid in virulence of Campylobacter jejuni 81-176.

Authors:  D J Bacon; R A Alm; D H Burr; L Hu; D J Kopecko; C P Ewing; T J Trust; P Guerry
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Campylobacter jejuni induces secretion of proinflammatory chemokines from human intestinal epithelial cells.

Authors:  Lan Hu; Thomas E Hickey
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

9.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.

Authors:  Rachel M McLoughlin; Brendan J Jenkins; Dianne Grail; Anwen S Williams; Ceri A Fielding; Clare R Parker; Matthias Ernst; Nicholas Topley; Simon A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

10.  The HS:1 serostrain of Campylobacter jejuni has a complex teichoic acid-like capsular polysaccharide with nonstoichiometric fructofuranose branches and O-methyl phosphoramidate groups.

Authors:  David J McNally; Harold C Jarrell; Jianjun Li; Nam H Khieu; Evgeny Vinogradov; Christine M Szymanski; Jean-Robert Brisson
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

View more
  27 in total

1.  Clostridium butyricum activates TLR2-mediated MyD88-independent signaling pathway in HT-29 cells.

Authors:  Quanxin Gao; Lili Qi; Tianxing Wu; Jinbo Wang
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis.

Authors:  B Otto; L-M Haag; A Fischer; R Plickert; A A Kühl; U B Göbel; M M Heimesaat; S Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 3.  Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection.

Authors:  Martin Stahl; Bruce A Vallance
Journal:  Gut Microbes       Date:  2015-04-01

Review 4.  Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries.

Authors:  Amanda E Schnee; William A Petri
Journal:  Curr Opin Infect Dis       Date:  2017-06       Impact factor: 4.915

Review 5.  Colonization properties of Campylobacter jejuni in chickens.

Authors:  C Pielsticker; G Glünder; S Rautenschlein
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-03-17

6.  The Campylobacter jejuni transcriptional regulator Cj1556 plays a role in the oxidative and aerobic stress response and is important for bacterial survival in vivo.

Authors:  Ozan Gundogdu; Dominic C Mills; Abdi Elmi; Melissa J Martin; Brendan W Wren; Nick Dorrell
Journal:  J Bacteriol       Date:  2011-06-03       Impact factor: 3.490

7.  Deciphering the contribution of human meningothelial cells to the inflammatory and antimicrobial response at the meninges.

Authors:  Pierre-Joseph Royer; Andrew J Rogers; Karl G Wooldridge; Patrick Tighe; Jafar Mahdavi; Michael G Rittig; Dlawer Ala'Aldeen
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

8.  Comparative kinetics of Escherichia coli- and Staphylococcus aureus-specific activation of key immune pathways in mammary epithelial cells demonstrates that S. aureus elicits a delayed response dominated by interleukin-6 (IL-6) but not by IL-1A or tumor necrosis factor alpha.

Authors:  Juliane Günther; Kathrin Esch; Norbert Poschadel; Wolfram Petzl; Holm Zerbe; Simone Mitterhuemer; Helmut Blum; Hans-Martin Seyfert
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

9.  Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells.

Authors:  Abdi Elmi; Eleanor Watson; Pamela Sandu; Ozan Gundogdu; Dominic C Mills; Neil F Inglis; Erin Manson; Lisa Imrie; Mona Bajaj-Elliott; Brendan W Wren; David G E Smith; Nick Dorrell
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

10.  Participation of the Cytoskeletal and Lysosomal Compartments in Campylobacter jejuni Invasion of Caco-2 cells, the Cellular Response by Morphometric Analysis and the Presence of Cytokine and Chemokine Transcripts.

Authors:  B B Fonseca; I L Santos; D A Rossi; R T Melo; T G Araújo; C U Vieira; E P Mendonça; M E Beletti
Journal:  Indian J Microbiol       Date:  2012-11-11       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.